Mathieu Boone

646 total citations
28 papers, 273 citations indexed

About

Mathieu Boone is a scholar working on Pulmonary and Respiratory Medicine, Genetics and Surgery. According to data from OpenAlex, Mathieu Boone has authored 28 papers receiving a total of 273 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pulmonary and Respiratory Medicine, 10 papers in Genetics and 7 papers in Surgery. Recurrent topics in Mathieu Boone's work include Glioma Diagnosis and Treatment (10 papers), Brain Metastases and Treatment (7 papers) and Meningioma and schwannoma management (3 papers). Mathieu Boone is often cited by papers focused on Glioma Diagnosis and Treatment (10 papers), Brain Metastases and Treatment (7 papers) and Meningioma and schwannoma management (3 papers). Mathieu Boone collaborates with scholars based in France, United States and Canada. Mathieu Boone's co-authors include Bruno Chauffert, Ariel Mueller, Andreas H. Taenzer, Shahzad Shaefi, Brian D. Sites, Martine Roussel, Olivier Godefroy, D. Le Gars, Marie Blonski and Aline Houessinon and has published in prestigious journals such as Neuroscience & Biobehavioral Reviews, Anesthesia & Analgesia and BMC Cancer.

In The Last Decade

Mathieu Boone

26 papers receiving 271 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mathieu Boone France 9 91 69 66 60 44 28 273
Thomas F. Rahlfs United States 9 16 0.2× 31 0.4× 40 0.6× 43 0.7× 148 3.4× 17 301
Katherine Hagan United States 12 12 0.1× 62 0.9× 46 0.7× 45 0.8× 204 4.6× 23 384
Manxu Zhao United States 5 80 0.9× 69 1.0× 10 0.2× 71 1.2× 125 2.8× 12 378
Jiakai Lu China 13 40 0.4× 173 2.5× 7 0.1× 46 0.8× 62 1.4× 46 372
Kiril Chtraklin United States 12 128 1.4× 19 0.3× 46 0.7× 18 0.3× 25 0.6× 26 520
Xinyu Nan China 6 211 2.3× 20 0.3× 11 0.2× 272 4.5× 24 0.5× 15 367
A N Hasso United States 8 11 0.1× 84 1.2× 78 1.2× 21 0.3× 90 2.0× 9 320
Anh Dang United States 7 9 0.1× 21 0.3× 41 0.6× 35 0.6× 167 3.8× 11 265
Gerd Scheiber Germany 6 24 0.3× 39 0.6× 8 0.1× 44 0.7× 120 2.7× 11 305
Anita Rampersad United States 9 37 0.4× 304 4.4× 29 0.4× 36 0.6× 16 0.4× 14 436

Countries citing papers authored by Mathieu Boone

Since Specialization
Citations

This map shows the geographic impact of Mathieu Boone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mathieu Boone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mathieu Boone more than expected).

Fields of papers citing papers by Mathieu Boone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mathieu Boone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mathieu Boone. The network helps show where Mathieu Boone may publish in the future.

Co-authorship network of co-authors of Mathieu Boone

This figure shows the co-authorship network connecting the top 25 collaborators of Mathieu Boone. A scholar is included among the top collaborators of Mathieu Boone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mathieu Boone. Mathieu Boone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Martínez‐Camblor, Pablo, et al.. (2023). Variables associated with cortical motor mapping thresholds: A retrospective data review with a unique case of interlimb motor facilitation. Frontiers in Neurology. 14. 1150670–1150670. 1 indexed citations
3.
Étienne-Selloum, Nelly, Mathieu Boone, Henri Sevestre, et al.. (2021). Expression Analysis of α5 Integrin Subunit Reveals Its Upregulation as a Negative Prognostic Biomarker for Glioblastoma. Pharmaceuticals. 14(9). 882–882. 5 indexed citations
4.
5.
6.
Boone, Mathieu, Hung‐Mo Lin, Xiaoyu Liu, et al.. (2021). Processed intraoperative burst suppression and postoperative cognitive dysfunction in a cohort of older noncardiac surgery patients. Journal of Clinical Monitoring and Computing. 36(5). 1433–1440. 8 indexed citations
7.
Jinadasa, Sayuri P., Qing Ruan, Sunjay Sharma, et al.. (2020). Hemorrhagic Complications of Invasive Intracranial Pressure Monitor Placement in Acute Liver Failure: Outcomes of a Single-Center Protocol and Comprehensive Literature Review. Neurocritical Care. 35(1). 87–102. 8 indexed citations
8.
Pollard, Richard J., et al.. (2020). Neurophysiologic Intraoperative Monitoring for Spine Surgery: A Practical Guide From Past to Present. Journal of Intensive Care Medicine. 36(11). 1237–1249. 11 indexed citations
9.
Boone, Mathieu, et al.. (2020). Economic Burden of Postoperative Neurocognitive Disorders Among US Medicare Patients. JAMA Network Open. 3(7). e208931–e208931. 82 indexed citations
10.
Mueller, Ariel, et al.. (2020). Risk Factors for Delayed Extubation Following High Posterior Cervical and Occipital Fusion. Journal of Neurosurgical Anesthesiology. 34(1). 64–68. 4 indexed citations
11.
Étienne-Selloum, Nelly, Marie Blonski, Luc Taillandier, et al.. (2019). Long-term survival in patients with recurrent glioblastoma treated with bevacizumab: a multicentric retrospective study. Journal of Neuro-Oncology. 144(2). 419–426. 9 indexed citations
12.
Rhun, Émilie Le, Patrick Devos, Véronique Bourg, et al.. (2019). Complementary and alternative medicine use in glioma patients in France. Journal of Neuro-Oncology. 145(3). 487–499. 6 indexed citations
13.
Attencourt, Christophe, Alexandre Coutté, Mathieu Boone, et al.. (2018). Combining genomic analyses with tumour-derived slice cultures for the characterization of an EGFR-activating kinase mutation in a case of glioblastoma. BMC Cancer. 18(1). 964–964. 5 indexed citations
14.
Coutté, Alexandre, Marie Blonski, Émilie Le Rhun, et al.. (2017). Temozolomide and Bevacizumab Induction before Chemoradiotherapy in Patients with Bulky Glioblastoma and/or with Severe Neurological Impairment. Journal of Cancer. 8(8). 1417–1424. 8 indexed citations
15.
Boone, Mathieu, Martine Roussel, Bruno Chauffert, D. Le Gars, & Olivier Godefroy. (2016). Prevalence and profile of cognitive impairment in adult glioma: a sensitivity analysis. Journal of Neuro-Oncology. 129(1). 123–130. 35 indexed citations
16.
Houessinon, Aline, Mathieu Boone, Jean‐Marc Constans, P. Toussaint, & Bruno Chauffert. (2015). Sustained Response of a Clivus Chordoma to Erlotinib after Imatinib Failure. Case Reports in Oncology. 8(1). 25–29. 14 indexed citations
17.
Noal, Sabine, et al.. (2014). Two Cases of Fatal Encephalopathy Related to Ifosfamide: An Adverse Role of Aprepitant. Case Reports in Oncology. 7(3). 669–672. 16 indexed citations
18.
Boone, Mathieu, Marie Blonski, Alexandre Coutté, et al.. (2012). Upfront Bevacizumab and Temozolomide or Fotemustine before Radiotherapy for Patients with Glioblastoma and Severe Neurological Impairment at Diagnosis. Case Reports in Oncology. 5(3). 530–536. 7 indexed citations
19.
Boone, Mathieu, et al.. (2010). Des troubles neurologiques persistants. La Revue de Médecine Interne. 31(9). 643–644.
20.
Boone, Mathieu. (1999). Assessment of adult-residual ADD (ARADD) using neurocognitive and self-report measures. Archives of Clinical Neuropsychology. 14(8). 763–764. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026